SCHEMBL23599043

SCHEMBL23599043

CNCN1CCCC1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4396508 0.82 PIK3CD (0.52)
SCHEMBL13811581 0.79 PIK3CD (0.50)
SCHEMBL1918653 0.79 KMT2A (0.65)
SCHEMBL13811574 0.78 PIK3CD (0.48)
SCHEMBL2128234 0.76 PIK3CD (0.47)
SCHEMBL680486 0.76 KMT2A (0.57)
SCHEMBL1306684 0.75 PIK3CD (0.46)
Dimethylamine SCHEMBL121939 0.75 KMT2A (0.56)
Imuracetam SCHEMBL1660951 0.75 KMT2A (0.56)
SCHEMBL1306680 0.75 CHRM2 (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212164-A1 ANNULATED 2-AMINO-3-CYANO THIOPHENES AND DERIVATIVES FOR THE TREATMENT OF CANCER BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2023-07-06 US disclosed
WO-2021129824-A1 NEW-TYPE K-RAS G12C INHIBITOR 微境生物医药科技(上海)有限公司 2021-07-01 WO disclosed